EMEA-000205-PIP02-11-M07

Human medicines European public assessment report (EPAR): Rilonacept FGK Representative Service GmbH , rilonacept, Status: Application withdrawn

Procedural guidance to scientific committeesꞌ members and experts on completing the European Medicines Agencyꞌs declaration of interests in the Experts Management Tool

Minutes of the PRAC meeting 5-8 May 2025

Human medicines European public assessment report (EPAR): Orfadin, nitisinone, Date of authorisation: 21/02/2005, Revision: 22, Status: Authorised

Strengthening supply chain of anti-D immunoglobulins

Recommendations of the Executive Steering Group on Shortages and Safety of Medicinal Products to address anti-D immunoglobulin supply chain vulnerabilities

Human medicines European public assessment report (EPAR): Neoatricon, dopamine hydrochloride, Date of authorisation: 27/05/2024, Revision: 1, Status: Authorised

Agenda of the HMPC meeting 7-9 July 2025

First EMA-ACRO bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 2 September 2025